Bill
Bill > SB650
NH SB650
NH SB650Relative to use of cannabis products for therapeutic purposes by alternative treatment centers.
summary
Introduced
01/07/2026
01/07/2026
In Committee
03/18/2026
03/18/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
This bill permits alternative treatment centers to use certain cannabis products for therapeutic purposes.
AI Summary
This bill allows alternative treatment centers, which are facilities that provide medical cannabis to registered patients, to use certain cannabis products for therapeutic purposes. Specifically, it permits these centers to acquire and use CBD (cannabidiol) and other hemp-derived non-intoxicating cannabinoids, as well as cannabis concentrate and cannabis-infused products made from them, even if these are not produced within New Hampshire. However, these products must be tested for contaminants and cannabinoid profiles, and alternative treatment centers are prohibited from using hemp-derived products that contain more than 0.3 percent tetrahydrocannabinol (THC) by dry weight, including any THC isomer variants like delta-8 or delta-9 THC, or any synthetic THC.
Committee Categories
Justice
Sponsors (9)
David Rochefort (R)*,
Karen Ebel (D),
Dan Innis (R),
Tim McGough (R),
Carol McGuire (R),
Keith Murphy (R),
Yury Polozov (R),
Victoria Sullivan (R),
Lucy Weber (D),
Last Action
Committee Report: Referred to Interim Study, 03/26/2026, Vote 3-1; Senate Calendar 11 (on 03/18/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://gc.nh.gov/bill_Status/billinfo.aspx?id=1278&inflect=2 |
| BillText | https://gc.nh.gov/bill_status/legacy/bs2016/billText.aspx?sy=2026&id=1278&txtFormat=html |
Loading...